The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Triglyceride–to–High-Density-Lipoprotein-Cholesterol Ratio is an Index of Heart Disease Mortality and of Incidence of Type 2 Diabetes Mellitus in Men
Abstract
Background: High triglyceride (TG) and low high-density lipoprotein cholesterol (HDL-C) impart risk for heart disease. This study examines the relationships of TG/HDL-C ratio to mortality from all causes, coronary heart disease (CHD), or cardiovascular disease (CVD). Subjects and Methods: Survival analysis was done in 39,447 men grouped by TG/HDL-C ratio cut point of 3.5 and for metabolic syndrome. National Death Index International Classification of Diseases ( ICD-9 and ICD-10) codes were used for CVD and CHD deaths occurring from 1970 to 2008. Incidence of type 2 diabetes mellitus (DM) according to ratio was estimated in 22,215 men. Triglyceride/HDL-C ratio and cross-product of TG and fasting blood glucose (TyG index) were used in analysis. Results: Men were followed up for 581,194 person-years. Triglyceride/HDL-C ratio predicted CHD, CVD, and all-cause mortality after adjustment for established risk factors and non–HDL-C. Mortality rates were higher in individuals with a high ratio than in those with a low ratio. Fifty-five percent of men had metabolic syndrome that was also predictive of CHD, CVD, and all-cause mortality. Annual incidence of DM was 2 times higher in men with high TG/HDL-C ratio than in those with a low ratio. Individuals with high TG/HDL-C ratio had a higher incidence of DM than those with a low ratio. The TyG index was not equally predictive of causes of mortality to TG/HDL-C, but both were equally predictive of diabetes incidence. Conclusions: Triglyceride/HDL-C ratio predicts CHD and CVD mortality as well as or better than do metabolic syndrome in men. Also, a high ratio predisposes to DM. The TyG index does not predict CHD, CVD, or all-cause mortality equally well, but like TG/HDL-C ratio, it predicts DM incidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Self-citationSarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes
Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.005 · Cited by 531 · cited 1×
“Hypertriglyceridemia is also frequently associated with impaired fasting glucose, impaired glucose tolerance, insulin resistance, type 2 diabetes mellitus (DM), and metabolic syndrome.(3,4) Elevated TGs are commonly associated with a lipoprotein phenotype designated ‘‘atherogenic dyslipidemia’’(5); this includes reduc…”
BackgroundHypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00033-2 · Cited by 525
Self-citationHanak, V., Munoz, J., Teague, J., Stanley, A., & Bittner, V. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.069 · Cited by 167 · cited 2×
“Hanak et al.(16) found a high correlation between the ratio and low-density lipoprotein phenotype B (atherogenic dyslipidemia).”
Background
Cited by
Bello-Chavolla, O. Y., Almeda-Valdes, P., Gomez-Velasco, D., Viveros-Ruiz, T., Cruz-Bautista, I., Romo-Romo, A., Sánchez-Lázaro, D., Meza-Oviedo, D., Vargas-Vázquez, A., Campos, O. A., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0883 · Cited by 664
Liu, X., Tan, Z., Huang, Y., Zhao, H., Liu, M., Yu, P., Ma, J., Zhao, Y., Zhu, W., & Wang, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01546-0 · Cited by 409
Elevated TyG Index Predicts Progression of Coronary Artery Calcification
Park, K., Ahn, C. W., Lee, S. B., Kang, S., Nam, J. S., Lee, B. K., Kim, J. H., & Park, J. S. (2019) · Diabetes Care · doi:10.2337/dc18-1920 · Cited by 392
Association between triglyceride glucose index and arterial stiffness in Korean adults
Lee, S. B., Ahn, C. W., Lee, B. K., Kang, S., Nam, J. S., You, J. H., Kim, M. J., Kim, M. K., & Park, J. S. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0692-1 · Cited by 305
da Silva, A., Caldas, A. P. S., Hermsdorff, H. H. M., Bersch-Ferreira, Â. C., Torreglosa, C. R., Weber, B., & Bressan, J. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0893-2 · Cited by 299
Metadata
- Authors
- Vega, G. L., Barlow, C. E., Grundy, S. M., Leonard, D., & DeFina, L. F.
- Venue
- Journal of Investigative Medicine
- Publisher
- SAGE Publications
- Published
- 2014-02
- Volume
- 62
- Issue
- 2
- Pages
- 345-349
- ISSN
- 1081-5589 (ISSN-L)
- 1708-8267
- OpenAlex
- W109758693
- Cited by
- 235
- References
- 5
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Triglyceride–to–High-Density-Lipoprotein-Cholesterol Ratio is an Index of Heart Disease Mortality and of Incidence of Type 2 Diabetes Mellitus in Men. https://app.cochat.ai/papers/10.2310/jim.0000000000000044
- The paper
- Vega, G. L., Barlow, C. E., Grundy, S. M., Leonard, D., & DeFina, L. F. (2014). Triglyceride–to–High-Density-Lipoprotein-Cholesterol Ratio is an Index of Heart Disease Mortality and of Incidence of Type 2 Diabetes Mellitus in Men. Journal of Investigative Medicine. https://doi.org/10.2310/jim.0000000000000044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.